Im concerned any background research by instos would highlight DNDN performance.
You would think the drop in SP lately could scare any major investment here too.
If only DNDN didnt get thown out like it did. FYI it is now half of pre nasdaq aprovel levels.
How only hope is that PRR is not like DNDN but unique in the fact it has global coverage and more than one product. with better future potential.
Time will tell and thats why I dont think this will get back to 40c soon. Instos do do research
- Forums
- ASX - By Stock
- prima biomed and it's inclusion to the asx300
Im concerned any background research by instos would highlight...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
33.5¢ |
Change
-0.100(23.0%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 23.0¢ | $16.23M | 50.19M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 704297 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.5¢ | 102135 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 704297 | 0.330 |
6 | 95226 | 0.325 |
8 | 320688 | 0.320 |
5 | 96798 | 0.315 |
5 | 162491 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.335 | 102135 | 2 |
0.340 | 75209 | 1 |
0.345 | 172909 | 5 |
0.350 | 167499 | 5 |
0.355 | 93526 | 4 |
Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |